| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |